1. Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
    Laura M. Urbanski et al, 2018, WIREs RNA CrossRef
  2. Involvement of partial EMT in cancer progression
    Masao Saitoh, 2018, The Journal of Biochemistry CrossRef
  3. Alternative Splicing: A New Therapeutic Target for Ovarian Cancer
    Shijie Yao et al, 2022, Technology in Cancer Research & Treatment CrossRef
  4. Human cytomegalovirus ie2 affects the migration of glioblastoma by mediating the different splicing patterns of RON through hnRNP A2B1
    Shuzhen Liang et al, 2019, NeuroReport CrossRef
  5. Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities
    Mosebo Armstrong Manabile et al, 2023, Cancers CrossRef
  6. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines
    ZHAOHUI LI et al, 2016, Oncology Reports CrossRef
  7. Splicing and cancer: Challenges and opportunities
    Patricia P. Coltri et al, 2019, WIREs RNA CrossRef
  8. The HNRNPA2B1–MST1R–Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer
    Amit Gupta et al, 2020, Laboratory Investigation CrossRef
  9. Targeted splicing therapy: new strategies for colorectal cancer
    Yifeng Zheng et al, 2023, Frontiers in Oncology CrossRef
  10. Alternative splicing: An important regulatory mechanism in colorectal carcinoma
    Jianyi Wang et al, 2021, Molecular Carcinogenesis CrossRef
  11. Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis
    Simon Braun et al, 2018, Nature Communications CrossRef
  12. Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics
    Ling Li et al, 2023, Genes CrossRef
  13. A promising novel formulation for articular cartilage regeneration: Preclinical evaluation of a treatment that produces SOX9 overexpression in human synovial fluid cells
    Ivan Delgado‑Enciso et al, 2017, Molecular Medicine Reports CrossRef
  14. Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy
    Joseph Kim et al, 2023, Cell Death & Differentiation CrossRef
  15. Influence of transcriptional variants on metastasis
    Joice De Faria Poloni et al, 2018, RNA Biology CrossRef
  16. Targeting Splicing Factor SRSF6 for Cancer Therapy
    Wenting She et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  17. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
    Cláudia Bessa et al, 2020, International Journal of Molecular Sciences CrossRef
  18. The HNRNPF/H RNA binding proteins and disease
    Tayvia Brownmiller et al, 2023, WIREs RNA CrossRef